T. Lotan

Large Cell Neuroendocrine Prostate Cancer: Large Is Not Small

H. Beltran, F. Karzai, David J. VanderWeele, 2024, The oncologist.

Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma

P. Pierorazio, M. Allaf, M. Gorin, 2024, Scientific reports.

PTEN Loss Is Associated with Adverse Outcomes in the Setting of Salvage Radiation Therapy.

A. Mendes, L. Oliveira, S. Nourmohammadi Abadchi, 2024, European urology oncology.

RAD21 promotes oncogenesis and lethal progression of prostate cancer

P. Scheet, M. V. Vander Heiden, W. Abida, 2024, Proceedings of the National Academy of Sciences of the United States of America.

Epigenome‐wide association study of prostate cancer in African American men identified differentially methylated genes

J. Dhillon, K. Yamoah, Rana Falahat, 2024, Cancer medicine.

High-Grade, Non-Sarcomatoid Chromophobe Renal Cell Carcinoma: A Series of 22 Cases with Novel Molecular Features on A Subset.

Aparna Pallavajjala, Pedram Argani, Yasser Ged, 2024, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Olaparib Without Androgen Deprivation for High-Risk Biochemically Recurrent Prostate Cancer Following Prostatectomy: A Nonrandomized Controlled Trial.

E. Davicioni, M. Carducci, M. Eisenberger, 2024, JAMA oncology.